Advertisement

Topics

Retractable Technologies, Inc. Reports Sale of Common Stock

12:54 EDT 24 Aug 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Retractable Technologies, Inc. (NYSE American: RVP), (“RTI”) reports that on August 23, 2017, RTI issued and sold to Thomas J. Shaw, its founder, President, Chief Executive Officer, and majority shareholder, one million shar...

Other Sources for this Article

Retractable Technologies, Inc.
Douglas W. Cowan, 888-806-2626 or 972-294-1010
Vice President and Chief Financial Officer

NEXT ARTICLE

More From BioPortfolio on "Retractable Technologies, Inc. Reports Sale of Common Stock"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...